Cita APA

A, A., H, C., EA, M., J, E., K, A., S, G., . . . D, B. (2026). GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

Citación estilo Chicago

A, Adamska, et al. GSPT1-specific Protein Degradation Is Effective in Preclinical Models of Chemoresistant MYCN-amplified Neuroblastoma. 2026.

Cita MLA

A, Adamska, et al. GSPT1-specific Protein Degradation Is Effective in Preclinical Models of Chemoresistant MYCN-amplified Neuroblastoma. 2026.